Disclosed herein are substituted cyclohexene TLR4 signaling pathway modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
本文披露了化学式I的取代环己烯TLR4信号通路调节剂,其制备方法,制药组合物以及使用方法。
Tetrahydrocarbazole Inhibitors Of SIRT1 Receptors
申请人:Auspex Pharmaceuticals, Inc.
公开号:US20170190664A1
公开(公告)日:2017-07-06
Described are deuterium-substituted tetrahydrocarbazole compounds of Formulae I, II, or III which are inhibitors of sirtuin 1 (SIRT1). Also described are pharmaceutical compositions comprising the deuterium-substituted tetrahydrocarbazole compounds, and methods of use thereof.
Disclosed herein are deuterated derivatives of TAK-242 of Formula (I) which are modulators of TLR4 signalling pathway, pharmaceutical compositions thereof and methods of use thereof. Formula (I)